首页> 外文OA文献 >Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
【2h】

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

机译:使用患者报告的患者的常见术语标准对不良事件的常见术语标准进行癌症患者的化疗毒性监测(Pro-CTCAE)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Introduction Systematic documentation of chemotoxicities in outpatient clinics is challenging. Incorporating patient-reported outcome (PRO) measures in clinical workflows can be an efficient strategy to strengthen the assessment of symptomatic treatment toxicities in oncology clinical practice. We compared the adequateness, feasibility, and acceptability of toxicity documentation using systematic, prospective, application of the PRO Common Toxicity Criteria for Adverse Events (PRO-CTCAE) tool. Methods At a comprehensive cancer center, data abstraction of electronic health record reviews elucidated current methods and degree of chemotoxicity documentation. Web-based 32-item PRO-CTCAE questionnaires, administered in ambulatory clinics of patients receiving chemotherapy, captured chemotoxicities and respective severities. Patient telephone surveys assessed whether healthcare providers had addressed chemotoxicities to the patients’ satisfaction. Results Over a broad demographic of 497 patients receiving chemotherapy, 90% (95% CI 84–96%) with significant chemotoxicities (n = 107) reported that their providers had discussed toxicities with them; of these, 70% received a therapy management change, while among the rest, 17% desired a change in management. Of patients surveyed, 91% (95% CI 82–99%) were satisfied with their current chemotoxicity management. Clinician chart documentation varied greatly; descriptors rather than numerical grading scales were typically used. Although 93% of patients were willing to complete the PRO survey, only 50% thought that it would be acceptable to complete this survey at routine clinic visits. Conclusion Use of PRO-CTCAE in routine clinical practice promotes systematic evaluation of symptomatic toxicities and improves the clarity, consistency, and efficiency of clinician documentation; however, methods to improve patient willingness to complete this tool routinely are needed.
机译:摘要介绍门诊诊所中嗜化毒性的系统文献挑战。纳入临床工作流程中的患者报告的结果(Pro)措施可以是加强对肿瘤学诊所症状毒性的评估的有效策略。我们使用系统,前瞻性应用于不良事件(Pro-CTCAE)工具的Pro常见毒性标准来比较毒性文件的充足性,可行性和可接受性。方法在综合癌症中心,电子健康记录的数据抽象评论阐明了当前的方法和嗜毒性文件程度。基于网络的32项Pro-CTCAE问卷调查问卷,在接受化疗,捕获嗜疗毒性和各个严重程度的患者的动态诊所。患者电话调查评估医疗保健提供者是否已向患者的满意度解决了趋化性。结果在接受化疗的广泛人口方面,90%(95%CI 84-96%),具有显着的嗜毒毒性(n = 107),报告说,其供应商与他们讨论了毒性;其中,70%收到了治疗管理变革,而其余部分在其余的情况下,预期改变了17%。对调查的患者,对目前的嗜毒性管理感到满意91%(95%CI 82-99%)。临床医生图文件变化大大变化;通常使用描述符而不是数值分级尺度。虽然93%的患者愿意完成专业调查,但只有50%的人认为在常规诊所访问中完成这项调查是可以接受的。结论使用Pro-CTCAE在常规临床实践中促进对症状毒性的系统评价,提高了临床文献的清晰度,一致性和效率;但是,需要改善患者愿意常规完成此工具的方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号